$120 Million Medicaid Fraud; Omnicare; Riisperdal; Tennessee Contracts reveals Kickbacks

TOP TEN FRAUD CASES IN GOVT WASTE 2008 Medicaid & DrugsMedicaidGeneric Drug PricingThe DrugsGlossary Contact Us.Pharmacist Whistleblower Recovers Over $120 Million In Medicaid Fraud False Claims Act Settlements Walgreens Pays $35 Million · CVS Pays $37 Million Omnicare, Largest Nursing Home Pharmacy, Pays $50 Million Omnicare Switching Settlement · Omnicare Kickbacks Settlement U.S. Department of Justice Joins Chicago Pharmacist’s Qui Tam Case Alleging Johnson & Johnson Paid Kickbacks For Nursing Homes Prescriptions The United States Department of Justice filed a complaint in Boston federal court today alleging that pharmaceutical manufacturer Johnson & Johnson committed Medicaid fraud by paying Omnicare pharmacies kickbacks for recommending that nursing home patients use Risperdal® and other Johnson & Johnson drugs. Omnicare is the nation’s largest pharmacy for nursing homes. The case against Johnson & Johnson was initiated by a Chicago pharmacist, Bernard Lisitza, who was fired by Omnicare after he challenged the Risperdal® kickbacks and other improper practices. According to the government’s complaint, Johnson & Johnson paid tens of millions of dollars in kickbacks to Omnicare, the nation’s largest pharmacy for nursing homes. The kickbacks were disguised as “market share rebate” agreements, which paid the pharmacy for successfully recommending Johnson & Johnson drugs. Lisitza first identified these “market share rebates” as kickbacks in a 2003 qui tam complaint filed by his attorneys, Behn & Wyetzner, Chartered of Chicago, Illinois. Read More Whistleblowers Pharmacists have initiated a number of highly successful qui tam actions under the False Claims Act. As the front line professionals responsible for dispensing medications to Medicaid beneficiaries, pharmacists are particularly well suited to discover and report Medicaid fraud. The Walgreens settlement marks another successful result of actions taken by pharmacists to protect taxpayer funds. The pharmacist became a qui tam relator after discovering the drug switching in processing transfers of prescriptions from Walgreens pharmacies. According to his qui tam Complaint, the pharmacist discovered the Medicaid fraud after noting that a Walgreens prescription was for ranitidine capsules rather than tablets, the industry standard. The pharmacist relator stated that Walgreens pharmacists told him that the pharmacy chain had set up its system to fill all ranitidine prescriptions as capsules regardless of what a physician had specifically prescribed. The same pharmacist relator also successfully pursued a qui tam action against CVS pharmacies for Medicaid fraud arising from drug switching, which resulted in a $37 million settlement. The initial qui tam case by the relator pharmacist was against his prior employer, Omnicare Inc., the nation's largest pharmacy for nursing homes. That Medicaid fraud case resulted in a $50 million settlement of False Claims Act allegations. A pharmacist's report to the government led to a $50 million settlement by Omnicare, Inc., the nation's largest pharmacy for nursing homes, to resolve federal and state charges that it defrauded Medicaid by switching generic drugs. The Omnicare case was the first to challenge generic drug switching, and served to strengthen Medicaid's price containment programs for generic drugs. The relator discovered the conduct which led to this settlement while he was a pharmacist at Omnicare. The pharmacist relator was represented by Behn & Wyetzner, Chartered. Read More The Attorneys Michael I. Behn is an experienced trial lawyer and former federal prosecutor who concentrates his practice in the civil prosecution of fraud. He founded the Chicago law firm, Behn & Wyetzner, Chartered and is a member of the Whistleblower Action Network. Mr. Behn primarily represents citizens who have reported fraud against the government, under the qui tam provisions of the state and federal False Claims Acts. Read More Linda Wyetzner is a seasoned trial lawyer and negotiator, with 20 years' experience representing employees in disputes with their employers. Ms. Wyetzner founded the Chicago law firm of Behn & Wyetzner, Chartered, and is a member of the Whistleblower Action Network. She primarily represents citizens who have reported fraud under the qui tam provisions of the federal and state False Claims Acts. Read More Walgreens Settlement By paying $35 million, Walgreens, the self-proclaimed "Pharmacy America Trusts®" settled allegations by pharmacist whistleblower Bernard Lisitza that it unlawfully defrauded Medicaid by switching prescriptions for ranitidine, the generic form of the brand-name drug Zantac®, and fluoxetine, the generic form of Prozac®. The Walgreens case was pursued by Lisitza as a “relator” under "qui tam" provisions of federal and state False Claims Acts, after he uncovered the conduct and reported the problem to the government. Relator Lisitza pursued the case with the assistance of his attorneys, Michael I. Behn and Linda Wyetzner, of Behn & Wyetzner, Chartered, in Chicago. Read More . Contact Us | Disclaimer © Copyright 2008 Behn & Wyetzner, Chartered. All rights reserved. Inactive links represent expected data not yet received. http://www.pharmacyfraudsettlement.com/

Skip to the navigation. Skip to the content. A Pharmacist-Whistleblower ResourceJohnson & JohnsonOverviewNews ReleaseFederal ReleaseU.S. ComplaintU.S. Exhibits- Exhibits 1-11- Exhibits 12-35- Exhibits 36-56Relator’s ComplaintThe Drugs
WalgreensCBS News ReportNews ReleaseCase SummaryFederal News ReleaseComplaintFederal SettlementParticipating StatesNAMFCU ReleaseArizona SettlementFlorida ReleaseIllinois ReleaseIndiana ReleaseMichigan SettlementCIAThe DrugsCompany News ReleaseThe Company
CVSNews Release2008 Top-Ten CaseCase SummaryFederal News ReleaseComplaintFederal SettlementParticipating StatesMichigan SettlementFlorida SettlementCIAThe DrugCompany News ReleaseThe Company
Omnicare KickbacksOverviewNews ReleaseFederal News ReleaseComplaintFederal SettlementCompany Press ReleaseRisperdal
Omnicare SwitchingOverviewNews ReleaseFederal News ReleaseComplaintFederal SettlementParticipating StatesArizona SettlementIllinois ReleaseMichigan SettlementTexas SettlementFlorida SettlementDelaware SettlementCIAThe DrugsCompany News Release
The ProsecutorsState LeadershipFederal LeadershipParticipating States
WhistleblowingPharmacist WhistleblowersBillions in RecoveriesWho Can Be SuedTaxpayers Against FraudBehn & Wyetzner
and TAF
The AttorneysMichael BehnLinda WyetznerBehn & Wyetzner
Medicaid & DrugsMedicaidGeneric Drug PricingThe DrugsGlossary
Contact Us.Pharmacist Whistleblower Recovers Over $120 Million
In Medicaid Fraud False Claims Act Settlements Walgreens Pays $35 Million · CVS Pays $37 Million
Omnicare, Largest Nursing Home Pharmacy, Pays $50 Million
Omnicare Switching Settlement · Omnicare Kickbacks Settlement
U.S. Department of Justice Joins Chicago Pharmacist’s Qui Tam Case Alleging Johnson & Johnson Paid Kickbacks For Nursing Homes Prescriptions
The United States Department of Justice filed a complaint in Boston federal court today alleging that pharmaceutical manufacturer Johnson & Johnson committed Medicaid fraud by paying Omnicare pharmacies kickbacks for recommending that nursing home patients use Risperdal® and other Johnson & Johnson drugs. Omnicare is the nation’s largest pharmacy for nursing homes. The case against Johnson & Johnson was initiated by a Chicago pharmacist, Bernard Lisitza, who was fired by Omnicare after he challenged the Risperdal® kickbacks and other improper practices.

According to the government’s complaint, Johnson & Johnson paid tens of millions of dollars in kickbacks to Omnicare, the nation’s largest pharmacy for nursing homes. The kickbacks were disguised as “market share rebate” agreements, which paid the pharmacy for successfully recommending Johnson & Johnson drugs. Lisitza first identified these “market share rebates” as kickbacks in a 2003 qui tam complaint filed by his attorneys, Behn & Wyetzner, Chartered of Chicago, Illinois.

Read More
Whistleblowers
Pharmacists have initiated a number of highly successful qui tam actions under the False Claims Act. As the front line professionals responsible for dispensing medications to Medicaid beneficiaries, pharmacists are particularly well suited to discover and report Medicaid fraud. The Walgreens settlement marks another successful result of actions taken by pharmacists to protect taxpayer funds.

The pharmacist became a qui tam relator after discovering the drug switching in processing transfers of prescriptions from Walgreens pharmacies. According to his qui tam Complaint, the pharmacist discovered the Medicaid fraud after noting that a Walgreens prescription was for ranitidine capsules rather than tablets, the industry standard. The pharmacist relator stated that Walgreens pharmacists told him that the pharmacy chain had set up its system to fill all ranitidine prescriptions as capsules regardless of what a physician had specifically prescribed.

The same pharmacist relator also successfully pursued a qui tam action against CVS pharmacies for Medicaid fraud arising from drug switching, which resulted in a $37 million settlement.

The initial qui tam case by the relator pharmacist was against his prior employer, Omnicare Inc., the nation's largest pharmacy for nursing homes. That Medicaid fraud case resulted in a $50 million settlement of False Claims Act allegations.

A pharmacist's report to the government led to a $50 million settlement by Omnicare, Inc., the nation's largest pharmacy for nursing homes, to resolve federal and state charges that it defrauded Medicaid by switching generic drugs. The Omnicare case was the first to challenge generic drug switching, and served to strengthen Medicaid's price containment programs for generic drugs. The relator discovered the conduct which led to this settlement while he was a pharmacist at Omnicare. The pharmacist relator was represented by Behn & Wyetzner, Chartered.

Read More
The Attorneys
Michael I. Behn is an experienced trial lawyer and former federal prosecutor who concentrates his practice in the civil prosecution of fraud. He founded the Chicago law firm, Behn & Wyetzner, Chartered and is a member of the Whistleblower Action Network. Mr. Behn primarily represents citizens who have reported fraud against the government, under the qui tam provisions of the state and federal False Claims Acts.

Read More

Linda Wyetzner is a seasoned trial lawyer and negotiator, with 20 years' experience representing employees in disputes with their employers.

Ms. Wyetzner founded the Chicago law firm of Behn & Wyetzner, Chartered, and is a member of the Whistleblower Action Network. She primarily represents citizens who have reported fraud under the qui tam provisions of the federal and state False Claims Acts.

Read More
Walgreens Settlement

By paying $35 million, Walgreens, the self-proclaimed "Pharmacy America Trusts®" settled allegations by pharmacist whistleblower Bernard Lisitza that it unlawfully defrauded Medicaid by switching prescriptions for ranitidine, the generic form of the brand-name drug Zantac®, and fluoxetine, the generic form of Prozac®. The Walgreens case was pursued by Lisitza as a “relator” under "qui tam" provisions of federal and state False Claims Acts, after he uncovered the conduct and reported the problem to the government. Relator Lisitza pursued the case with the assistance of his attorneys, Michael I. Behn and Linda Wyetzner, of Behn & Wyetzner, Chartered, in Chicago.

Read More
. Contact Us | Disclaimer

© Copyright 2008 Behn & Wyetzner, Chartered. All rights reserved.
Inactive links represent expected data not yet received.

http://www.pharmacyfraudsettlement.com/

Posted via web from ElyssaD's Posterous